Abstract
The effects of Semax heptapeptide on the resistance to acute hypobaric hypoxia and on hypoxic changes in the ECG chronotropic index were studied in 14- and 21-day-old pups. The resistance to hypoxia decreased with age. Hypoxic exposure caused bradycardia in both age groups. Semax reduced the bradycardiac reaction and exerted an antiarrhythmic effect without affecting the resistance to hypoxia.
Similar content being viewed by others
References
Ya. V. Krushinskaya.Improvement of the Resistance to Hemorrage and Hypobaric Hypoxia by Complex of Regulatory Peptides, Abstract of Cand. Biol. Sci. dissertation, Moscow (1996).
Recommendation for Experimental Study of Preparations, Offered for Clinical Tests as Antihypoxic Drugs [in Russian] Ed. L. D. Luk'yanova Moscow (1990).
N. P. Shabalov, V. K. Yaroslavskii, D. A. Khodov, and V. A. Lyubimenko,Asphyxia in Neonates [in Russian], Leningrad (1990).
I. P. Ashmarin, V. N. Nezavibat'ko, N. G. Levitskaya,et al., Neurosci. Res. Commun.,16, No. 2, 105–112 (1995).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 128, No. 8, pp. 161–164, August, 1999
Rights and permissions
About this article
Cite this article
Maslova, M.V., Krushinskaya, Y.V., Maklakova, A.S. et al. Effect of semax heptapeptide on rat heart activity during acute hypobaric hypoxia in the early postnatal period. Bull Exp Biol Med 128, 797–799 (1999). https://doi.org/10.1007/BF02433818
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02433818